Kcb. Tan et al., PLASMA CHOLESTERYL ESTER TRANSFER PROTEIN-ACTIVITY IN HYPERTHYROIDISMAND HYPOTHYROIDISM, The Journal of clinical endocrinology and metabolism, 83(1), 1998, pp. 140-143
Thyroid dysfunction is associated with multiple changes in lipoprotein
metabolism, and we have determined the effects of thyroid dysfunction
on plasma cholesteryl ester transfer protein (CETP) activity. CETP is
a plasma protein that mediates the exchange of cholesteryl ester and
triglyceride between plasma lipoproteins and plays an important role i
n high-density lipoprotein metabolism and in the reverse cholesterol t
ransport pathway. Plasma CETP activity was assayed in 18 hyperthyroid
and in 17 hypothyroid patients, before and after treatment, by measuri
ng the transfer of cholesteryl esters from exogenous radiolabeled high
-density lipoprotein to apolipoprotein B-containing lipoproteins. Plas
ma CETP activity was increased in hyperthyroid patients, compared with
their matched controls (22.11 +/- 8.92% transferred/5 mu L.4 h vs. 16
.75 +/- 6.48, P < 0.05), whereas in hypothyroid patients, plasma CETP
activity was decreased (11.14 +/- 4.84% transferred/5 mu L.4 h vs. 17.
26 +/- 7.13, P < 0.01). Plasma CETP activity decreased after treatment
of thyrotoxicosis, although a significant change was observed, mainly
in the severely thyrotoxic patients with free T-4 > 100 pmol/L (n = 1
1, 25.61 +/- 8.12% transferred/5 mu L.4 h vs. 21.71 plus/similar to 7.
84, P < 0.05). In the hypothyroid patients, there was a significant in
crease in plasma CETP activity after thyroxine replacement (11.14 +/-
4.84% transferred/5 mu L.4 h vs. 15.46 +/- 6.71, P < 0.01). There was
a strong positive correlation between log(free T-4) and plasma CETP ac
tivity (r = 0.51, P < 0.001). In summary, both hyper and hypothyroidis
m are associated with significant changes in plasma CETP activity, and
these changes are corrected when the patients have been rendered euth
yroid.